Historical claims and current interpretations of replicative aging

Nature Biotechnology

Volumn 20, Issue 7, 2002, Pages 682-688

  Wright, Woodring E ^a   Shay, Jerry W ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELLS; PHYSIOLOGY; TISSUE;

REPLICATIVE AGING;

BIOTECHNOLOGY;

AGE; AMINO ACID SEQUENCE; CELL AGING; CELL CULTURE; CELL DIVISION; CELL GROWTH; CELL PROLIFERATION; CHROMOSOME STRUCTURE; GROWTH INHIBITION; HOMEOSTASIS; HUMAN; HUMAN CELL; IN VIVO STUDY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SENESCENCE; TELOMERE; CELL DIFFERENTIATION; CLONING; DNA REPLICATION; GENETICS; METABOLISM; NEOPLASM; PHYSIOLOGY; SPECIES DIFFERENCE;

CELL AGING; CELL DIFFERENTIATION; CELL DIVISION; CELLS, CULTURED; CLONING, ORGANISM; DNA REPLICATION; HUMAN; NEOPLASMS; SPECIES SPECIFICITY; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TELOMERASE; TELOMERE; HUMANS;

TELOMERASE;

EID: 0035989631     PISSN: 10870156     EISSN: None     Source Type: Journal    
DOI: 10.1038/nbt0702-682     Document Type: Review

References (105)

1. The nature and causes of ageing
2. Advanced glycosylation: Chemistry, biology, and implications for diabetes and aging
3. The multistep nature of cancer
4. Specific association of human telomerase activity with immortal cells and cancer
5. A survey of telomerase activity in human cancer
6. Site-specific DNA damage at GGG sequence by oxidative stress may accelerate telomere shortening
7. Cytology of telomeres
8. Telomerase reverse transcriptase promotes cardiac muscle cell proliferation, hypertrophy, and survival
9. Emerging roles for telomerase in neuronal development and apoptosis
10. Telomerase activity in 'immortal' fish
11. Cellular senescence: Mitotic clock or culture shock?
12. Telomere dynamics in cancer progression and prevention: Fundamental differences in human and mouse telomere biology
13. Cellular senescence as a tumor-protection mechanism: The essential role of counting
14. The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita
15. A telomerase component is defective in the human disease dyskeratosis congenita
16. Telomere shortening and tumor formation by mouse cells lacking telomerase RNA
17. The p53 tumor suppressor protein does not regulate expression of its own inhibitor, MDM2, except under conditions of stress
18. Requirement for Ku80 in growth and immunoglobulin V(D)J recombination
19. Atm-deficient mice: A paradigm of ataxia telangiectasia
20. Tumorigenesis and a DNA repair defect in mice with a truncating Brca2 mutation
21. Postnatal growth failure, short life span, and early onset of cellular senescence and subsequent immortalization in mice lacking the xeroderma pigmentosum group G gene
22. Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF
23. Extended culture of mouse embryo cells without senescence: Inhibition by serum
24. Lack of replicative senescence in cultured rat oligodendrocyte precursor cells
25. Lack of replicative senescence in normal rodent glia
26. Telomere loss: Mitotic clock or genetic time bomb?
27. Agents that cause DNA double strand breaks lead to p16INK4a enrichment and the premature senescence of normal fibroblasts
28. Is β-galactosidase staining a marker of senescence in vitro and in vivo?
29. Senescence-like growth arrest induced by hydrogen peroxide in human diploid fibroblast F65 cells
30. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
31. Senescence of human fibroblasts induced by oncogenic Raf
32. Regulation of a senescence checkpoint response by the E2F1 transcription factor and p14(ARF) tumor suppressor
33. Immortalisation and transformation revisited
34. Aging. When do telomeres matter?
35. Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span
36. Extension of life-span by introduction of telomerase into normal human cells
37. Telomere biology and cellular aging in nonhuman primate cells
38. Formation of functional tissue from transplanted adrenocortical cells expressing telomerase reverse transcriptase
39. Cell aging in vivo and in vitro
40. Telomerase and cellular lifespan: Ending the debate?
41. The relation between lifespan of a species and the number of doublings of its cells in culture is an unresolved issue
42. Multistage carcinogenesis in cell culture
43. Normal human mammary epithelial cells spontaneously escape senescence and acquire genomic changes
44. Both Rb/p16/INK4a inactivation and telomerase activity are required to immortalize human epithelial cells
45. p16/pRb pathway alterations are required for bypassing senescence in human prostate epithelial cells
46. Human keratinocytes that express hTERT and also bypass a p16(INK4a)-enforced mechanism that limits life span become immortal yet retain normal growth and differentiation characteristics
47. Genetic and epigenetic changes in human epithelial cells immortalized by telomerase
48. Putative telomere-independent mechanisms of replicative aging reflect inadequate growth conditions
49. The effect of low oxygen tension on the in vitro-replicative life span of human diploid fibroblast cells and their transformed derivatives
50. Low oxygen concentration extends the lifespan of cultured human diploid cells
51. N-t-butyl hydroxylamine, a hydrolysis product of α-phenyl-N-t-butyl nitrone, is more potent in delaying senescence in human lung fibroblasts
52. Thymidine labelling index as a criterion of aging in vitro
53. Influence of oxygen and pH on plating efficiency and colony development of WI-38 and Vero cells
54. Methods for reducing the serum requirement for growth in vitro of nontransformed diploid fibroblasts
55. The relationships of animal age and caloric intake to cellular replication in vivo and in vitro: A review
56. Skeletal muscle satellite cells: Changes in proliferation potential as a function of age
57. Variation in the life-span of clones derived from human diploid cell strains
58. Intraclonal variation in proliferative potential of human diploid fibroblasts: Stochastic mechanism for cellular aging
59. Clonal selection, attenuation and differentiation in an in vitro model of hyperplasia
60. Colony size distributions as a measure of in vivo and in vitro aging
61. Telomeres shorten during aging
62. Loss of telomeric DNA during aging of normal and trisomy 21 human lymphocytes
63. E6 of human papillomavirus type 16 can overcome the M1 stage of immortalization in human mammary epithelial cells but not in human fibroblasts
64. Telomere shortening is proportional to the size of the G-rich telomeric 3′-overhang
65. Telomeres and telomerase in human leukemias
66. Refining the telomere - Telomerase hypothesis of aging and cancer
67. Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice
68. In vivo loss of telomeric repeats with age in humans
69. Telomerase activity in human intestine
70. Telomeric length and telomerase activity vary with age in peripheral blood cells obtained from normal individuals
71. Telomere shortening and decline in replicative potential as a function of donor age in human adrenocortical cells
72. p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis
73. Frequent p53 accumulation in the chronically sun-exposed epidermis and clonal expansion of p53 mutant cells in the epidermis adjacent to basal cell carcinoma
74. Involvement of follicular stem cells in forming not only the follicle but also the epidermis
75. The small intestine in old mice: Growth, alkaline phosphatase and disaccharidase activities, and deposition of amyloid
76. Stem cells: Attributes, cycles, spirals, pitfalls and uncertainties. Lessons for and from the crypt
77. In vivo proliferation and cell cycle kinetics of long-term self-renewing hematopoietic stem cells
78. Quiescence, cycling, and turnover in the primitive hematopoietic stem cell compartment
79. The relative quiescence of hematopoietic stem cells in nonhuman primates
80. Multiple pathways for the regulation of telomerase activity
81. Telomerase inhibitors
82. A protein-counting mechanism for telomere length regulation in yeast
83. The yeast telomere length counting machinery is sensitive to sequences at the telomere - Nontelomere junction
84. Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death
85. Telomere states and cell fates
86. Telomerase extends the lifespan of virus-transformed human cells without net telomere lengthening
87. A role for both RB and p53 in the regulation of human cellular senescence
88. Transient expression of human telomerase extends the life span of normal human fibroblasts
89. Subsenescent telomere lengths in fibroblasts immortalized by limiting amounts of telomerase
90. Preferential maintenance of critically short telomeres in mammalian cells heterozygous for mTert
91. The shortest telomere, not average telomere length, is critical for cell viability and chromosome stability
92. Regulation of telomerase activity in immortal cell lines
93. Lack of cell cycle regulation of telomerase activity in human cells
94. Telomerase-mediated telomere addition in vivo requires DNA primase and DNA polymerases alpha and delta
95. The Saccharomyces telomere-binding protein Cdc13p interacts with both the catalytic subunit of DNA polymerase alpha and the telomeraseassociated est1 protein
96. Expression of the RNA component of telomerase during human development and differentiation
97. Telomerase activity in human germline and embryonic tissues
98. Telomerase and differentiation in multicellular organisms: Turn it off, turn it on, and turn it off again
99. Shorter telomeres in dystrophic muscle consistent with extensive regeneration in young children
100. Myoblast senescence in muscular dystrophy
101. Defective myoblasts identified in Duchenne muscular dystrophy
102. Progressive telomere shortening and telomerase reactivation during hepatocellular carcinogenesis
103. Telomere shortening in chronic liver diseases
104. Telomere length in human liver diseases